Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas

Creative Commons License

Samia P., Oyieke K., Tunje D., Udwadia-Hegde A., Feemster K., Anlar B., ...More

CURRENT TREATMENT OPTIONS IN NEUROLOGY, vol.24, no.3, pp.99-110, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 24 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.1007/s11940-022-00710-x
  • Journal Name: CURRENT TREATMENT OPTIONS IN NEUROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
  • Page Numbers: pp.99-110
  • Keywords: Treatment, Antiviral agent, Subacute sclerosing panencephalitis, Measles complication, SSPE, MEASLES-VIRUS, INTRAVENTRICULAR INTERFERON, SSPE, EPIDEMIOLOGY, IMMUNIZATION, VACCINATION, INOSIPLEX, DISEASE, PATIENT, ALPHA
  • Hacettepe University Affiliated: Yes

Abstract

Purpose of the review Subacute sclerosing panencephalitis (SSPE) is a rare, slowly progressive, and frequently fatal neurodegenerative disorder caused by measles virus. The risk of SSPE remains significant globally, with fluctuating incidence noted in in tandem with measles vaccine uptake. This review aims to explore the current global status of SSPE, its treatment, and preventive measures.